Tag: Scandinavian

News

10/03/25

Use of supplements by breast cancer survivors linked to mixed outcomes

Studies

• Light to Moderate Alcohol Consumption and Cancer Incidence: The Norwegian Women and Health Cohort Study Cite
  Llaha F, Licaj I, Sharashova E, Ferrari P, Lukic M, Benjaminsen Borch K. Light to Moderate Alcohol Consumption and Cancer Incidence: The Norwegian Women and Health Cohort Study. Clinical Epidemiology. Informa UK Limited; 2025; Volume 17:807-821 10.2147/clep.s531643
• First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study Cite
  Ma Z, He W, Zhang Y, Mao X, Tapia J, Hall P, et al. First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study. BMJ. BMJ; 2025; 390:e085029 10.1136/bmj-2025-085029
• Dietary supplement use and life expectancy after breast cancer – The Danish Diet, Cancer and Health cohort Cite
  Kyrø C, Grand MK, Bigaard J, Rossing M, Knoop AS, Kroman N, et al. Dietary supplement use and life expectancy after breast cancer – The Danish Diet, Cancer and Health cohort. The Journal of Nutrition. Elsevier BV; 2025; 10.1016/j.tjnut.2025.09.035
• Dietary non-enzymatic antioxidant capacity and risk of breast cancer: the Swedish National March Cohort Cite
  Mariosa D, Ponzano M, Grotta A, Lagerros YT, Hantikainen E, Adami H, et al. Dietary non-enzymatic antioxidant capacity and risk of breast cancer: the Swedish National March Cohort. BMC Cancer. Springer Science and Business Media LLC; 2025; 25 10.1186/s12885-025-14658-z
• Overweight and Risk of Recurrence Following Neoadjuvant Chemotherapy in Breast Cancer Cite
  Møller AL, Borgquist S, Skarping I. Overweight and Risk of Recurrence Following Neoadjuvant Chemotherapy in Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2025; 10.1016/j.clbc.2025.06.009
• Effects of supervised exercise during neoadjuvant chemotherapy on tumour response in patients with breast cancer (Neo-train): a randomised controlled trial Cite
  Kjeldsted E, Ammitzbøll G, Lænkholm A, Rasic D, Ceballos SG, Jørgensen LB, et al. Effects of supervised exercise during neoadjuvant chemotherapy on tumour response in patients with breast cancer (Neo-train): a randomised controlled trial. Clinical Cancer Research. American Association for Cancer Research (AACR); 2025; 10.1158/1078-0432.ccr-25-0416
• Aprepitant use during chemotherapy and association with survival in women with early breast cancer Cite
  Botteri E, Hjorth S, Conforti F, Bagnardi V, Andreassen BK, Støer NC, et al. Aprepitant use during chemotherapy and association with survival in women with early breast cancer. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2025; 10.1093/jnci/djaf178
• Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study Cite
  Stenberg E, Ottosson J, Cao Y, Lagstam I, Näslund E. Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study. Obesity. Wiley; 2025; 10.1002/oby.24318
• Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up Cite
  Solmunde E, Pedersen RN, Nørgaard M, Mellemkjær L, Friis S, Ejlertsen B, et al. Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up. British Journal of Cancer. Springer Science and Business Media LLC; 2025; 10.1038/s41416-025-03112-3
• The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancer Cite
  Holm JB, Skovbjerg SB, Nielsen HM, Christiansen P, Bruun JM, Alsner J, et al. The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2025; 27 10.1186/s13058-025-02083-w
• CYP2D6 genotype and outcome in tamoxifen treated early breast cancer Cite
  Thorén L, Lindh JD, Molden E, Kristiansen Kringen M, Bergh J, Eliasson E, et al. CYP2D6 genotype and outcome in tamoxifen treated early breast cancer. Acta Oncologica. MJS Publishing, Medical Journals Sweden AB; 2025; 64:848-856 10.2340/1651-226x.2025.43208
• Risk of breast cancer among women with hypo‐ and hyperthyroidism: Results from a large nationwide cohort study Cite
  Jensen A, Gottschau M, Christensen J, Lindquist S, Aalborg GL, Rosthøj S, et al. Risk of breast cancer among women with hypo‐ and hyperthyroidism: Results from a large nationwide cohort study. International Journal of Cancer. Wiley; 2025; 10.1002/ijc.70007
• Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancer Cite
  Lund M, Corn G, Jensen M, Petersen T, Dalhoff K, Ejlertsen B, et al. Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancer. European Journal of Epidemiology. Springer Science and Business Media LLC; 2025; 10.1007/s10654-025-01228-7
• Mammographic density by time and breast: a retrospective cohort study from BreastScreen Norway Cite
  Moshina N, Gjesvik J, Hovda T, Koch HW, Backmann HA, Hofvind S. Mammographic density by time and breast: a retrospective cohort study from BreastScreen Norway. Breast Cancer Research. Springer Science and Business Media LLC; 2025; 27 10.1186/s13058-025-02037-2
• HbA1c levels and breast cancer prognosis in women without diabetes Cite
  Holm JB, Bruun JM, Christiansen P, Thomsen RW, Frystyk J, Cronin-Fenton D, et al. HbA1c levels and breast cancer prognosis in women without diabetes. BMC Cancer. Springer Science and Business Media LLC; 2025; 25 10.1186/s12885-025-14121-z
• Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort study Cite
  Skriver C, Cronin-Fenton D, Borgquist S, Hansen Viuff J, Alkner S, Rydén L, et al. Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort study. British Journal of Cancer. Springer Science and Business Media LLC; 2025; 10.1038/s41416-025-02974-x
• Risk reducing mastectomy in Norwegian BRCA1/2 carriers Cite
  Hyldebrandt HK, Stormorken AT, Vitelli V, Mæhle L, Schlichting E, Grindedal EM. Risk reducing mastectomy in Norwegian BRCA1/2 carriers. European Journal of Surgical Oncology. Elsevier BV; 2025; 51:109571 10.1016/j.ejso.2024.109571
• High comorbidity and tumor proliferation predict survival of localized breast cancer patients after curative surgery: A retrospective analysis of real-world data in Finland Cite
  Hollmén M, Löyttyniemi E, Juhanoja E, Vihinen P, Sundvall M. High comorbidity and tumor proliferation predict survival of localized breast cancer patients after curative surgery: A retrospective analysis of real-world data in Finland. Surgical Oncology. Elsevier BV; 2025; 58:102188 10.1016/j.suronc.2025.102188
• Cancers attributed to modifiable factors in Norway 2016–2020 Cite
  Berstad P, Haugan K, Knudsen MD, Nygård M, Ghiasvand R, Robsahm TE. Cancers attributed to modifiable factors in Norway 2016–2020. European Journal of Cancer. Elsevier BV; 2025; 217:115232 10.1016/j.ejca.2025.115232
• The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study Cite
  Nyqvist-Streng J, Helou M, Helou K, Chamalidou C, Kovács A, Parris TZ. The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2025; 10.1007/s10549-025-07610-z
• Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial Cite
  Faltinová M, Vehmanen L, Lyytinen H, Savolainen-Peltonen H, Virtanen A, Haanpää M, et al. Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07564-8
• Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial Cite
  Johansson A, Dar H, Nordenskjöld A, Perez-Tenorio G, Tobin NP, Yau C, et al. Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2024; 10.1093/jnci/djae268
• Alcohol consumption trajectories and risk of breast cancer among postmenopausal women: a Danish cohort study Cite
  Antoniussen CS, Proust-Lima C, Ibsen DB, Olsen A, Overvad K, Tjønneland A, et al. Alcohol consumption trajectories and risk of breast cancer among postmenopausal women: a Danish cohort study. European Journal of Epidemiology. Springer Science and Business Media LLC; 2024; 10.1007/s10654-024-01179-5
• Survival outcomes for HER2-low breast cancer: Danish national data Cite
  Sode M, Nielsen K, Jensen M, Berg T, Knoop A, Ejlertsen B, et al. Survival outcomes for HER2-low breast cancer: Danish national data. Acta Oncologica. MJS Publishing, Medical Journals Sweden AB; 2024; 63:878-886 10.2340/1651-226x.2024.41280
• High‐dose folic acid use and cancer risk in women who have given birth: A register‐based cohort study Cite
  Vegrim HM, Dreier JW, Igland J, Alvestad S, Gilhus NE, Gissler M, et al. High‐dose folic acid use and cancer risk in women who have given birth: A register‐based cohort study. Epilepsia. Wiley; 2024; 10.1111/epi.18146
• Breast cancer in women with previous gestational diabetes: a nationwide register-based cohort study Cite
  Christensen MH, Vinter CA, Olesen TB, Petersen MH, Nohr EA, Rubin KH, et al. Breast cancer in women with previous gestational diabetes: a nationwide register-based cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2024; 26 10.1186/s13058-024-01908-4
• Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems Cite
  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. American Medical Association (AMA); 2024; 10.1001/jama.2024.18575
• 326P Exploratory analysis of the association of systemic inflammation and breast cancer recurrence in the Optitrain randomised controlled trial Cite
  Rietz M, Mijwel S, Lindström L, Wengström Y, Rundqvist H. 326P Exploratory analysis of the association of systemic inflammation and breast cancer recurrence in the Optitrain randomised controlled trial. Annals of Oncology. Elsevier BV; 2024; 35:S351-S352 10.1016/j.annonc.2024.08.265
• Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: A prospective cohort study Cite
  Busund MK, Ursin G, Lund E, Chen SLF, Rylander C. Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: A prospective cohort study. Springer Science and Business Media LLC; 2024; 10.21203/rs.3.rs-4912071/v1
• Acetyl salicylic acid, COX-2 inhibitors and other NSAIDs and breast cancer survival in a Finnish population-based cohort Cite
  Malin M, Murto M, Arponen O, Siltari A, Artama M, Visvanathan K, et al. Acetyl salicylic acid, COX-2 inhibitors and other NSAIDs and breast cancer survival in a Finnish population-based cohort. Authorea, Inc.; 2024; 10.22541/au.172549517.74928122/v1
• Source-specific nitrate intake and all-cause mortality in the Danish Diet, Cancer, and Health Study Cite
  Bondonno NP, Pokharel P, Bondonno CP, Erichsen DW, Zhong L, Schullehner J, et al. Source-specific nitrate intake and all-cause mortality in the Danish Diet, Cancer, and Health Study. European Journal of Epidemiology. Springer Science and Business Media LLC; 2024; 10.1007/s10654-024-01133-5
• The effect of exercise and disease status on mobilization of anti-tumorigenic and pro-tumorigenic immune cells in women with breast cancer Cite
  Koivula T, Lempiäinen S, Neuvonen J, Norha J, Hollmén M, Sundberg CJ, et al. The effect of exercise and disease status on mobilization of anti-tumorigenic and pro-tumorigenic immune cells in women with breast cancer. Frontiers in Immunology. Frontiers Media SA; 2024; 15 10.3389/fimmu.2024.1394420
• Breast volume in non-obese females is related to breast adipose cell hypertrophy, inflammation, and COX2 expression Cite
  Gogg S, Nerstedt A, Smith U, Hansson E. Breast volume in non-obese females is related to breast adipose cell hypertrophy, inflammation, and COX2 expression. Journal of Plastic Surgery and Hand Surgery. MJS Publishing, Medical Journals Sweden AB; 2024; 59:83-88 10.2340/jphs.v59.40754
• A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression Cite
  Boman C, Liu X, Eriksson Bergman L, Sun W, Tranchell C, Toli MA, et al. A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression. British Journal of Cancer. Springer Science and Business Media LLC; 2024; 10.1038/s41416-024-02777-6
• The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer Cite
  Rewcastle E, Skaland I, Gudlaugsson E, Fykse SK, Baak JPA, Janssen EAM. The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07352-4
• Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study Cite
  Strell C, Smith DR, Valachis A, Woldeyesus H, Wadsten C, Micke P, et al. Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07358-y
• Breast Cancer Risk After Bariatric Surgery and Influence of Insulin Levels Cite
  Kristensson FM, Andersson-Assarsson JC, Peltonen M, Jacobson P, Ahlin S, Svensson P, et al. Breast Cancer Risk After Bariatric Surgery and Influence of Insulin Levels. JAMA Surgery. American Medical Association (AMA); 2024; 10.1001/jamasurg.2024.1169
• Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden Cite
  Yi H, Zhang N, Huang J, Zheng Y, Hong Qh, Sundquist J, et al. Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden. American Journal of Obstetrics and Gynecology. Elsevier BV; 2024; 10.1016/j.ajog.2024.05.011
• Impact of neoadjuvant compared to adjuvant chemotherapy on prognosis in patients with hormone-receptor positive / HER2-negative breast cancer: a propensity score matching population-based study Cite
  Hosseini-Mellner S, Wickberg Å, Karakatsanis A, Valachis A. Impact of neoadjuvant compared to adjuvant chemotherapy on prognosis in patients with hormone-receptor positive / HER2-negative breast cancer: a propensity score matching population-based study. The Breast. Elsevier BV; 2024;:103741 10.1016/j.breast.2024.103741
• Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival Cite
  Karihtala P, Leivonen S, Puistola U, Urpilainen E, Jääskeläinen A, Leppä S, et al. Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival. Breast Cancer Research. Springer Science and Business Media LLC; 2024; 26 10.1186/s13058-024-01812-x
• Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study Cite
  Blomqvist C, Vehmanen L, Kellokumpu-Lehtinen P, Huovinen R, Ruohola J, Penttinen H, et al. Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07252-7
• The incidence of male breast cancer in Klinefelter’s syndrome and its proposed mechanisms Cite
  Cook B, Nayar S. The incidence of male breast cancer in Klinefelter’s syndrome and its proposed mechanisms. European Journal of Cancer. Elsevier BV; 2024; 200:113885 10.1016/j.ejca.2024.113885
• Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study Cite
  Acs B, Hartman J, Sönmez D, Lindman H, Johansson AL, Fredriksson I. Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study. The Lancet Regional Health - Europe. Elsevier BV; 2024;:100886 10.1016/j.lanepe.2024.100886
• Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma Cite
  Neppelenbroek SI, Geurts YM, Aleman BM, Lugtenburg PJ, Rademakers SE, de Weijer RJ, et al. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2024; 10.1200/jco.23.01386
• Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer Cite
  Andersen HH, Bojesen SE, Johansen JS, Ejlertsen B, Berg T, Tuxen M, et al. Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2024; 10.1158/1055-9965.epi-23-1299
• Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study Cite
  Lindgren H, Ademi D, Godina C, Tryggvadottir H, Isaksson K, Jernström H. Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study. Cancer Causes & Control. Springer Science and Business Media LLC; 2024; 10.1007/s10552-023-01845-1
• Validity of self-reported night shift work among women with and without breast cancer Cite
  Vestergaard JM, Haug JND, Dalbøge A, Bonde JPE, Garde AH, Hansen J, et al. Validity of self-reported night shift work among women with and without breast cancer. Scandinavian Journal of Work, Environment & Health. Scandinavian Journal of Work, Environment and Health; 2024; 10.5271/sjweh.4142
• Every tenth malignant solid tumor attributed to overweight and alcohol consumption: a population-based cohort study Cite
  Seppä K, Heikkinen S, Ryynänen H, Albanes D, Eriksson JG, Härkänen T, et al. Every tenth malignant solid tumor attributed to overweight and alcohol consumption: a population-based cohort study. European Journal of Cancer. Elsevier BV; 2023;:113502 10.1016/j.ejca.2023.113502
• Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients Cite
  Vidarsdottir L, Olafsdottir EJ, Barkardottir RB, Bjarnadottir O, Jonasson JG, Sigurdsson S, et al. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients. npj Breast Cancer. Springer Science and Business Media LLC; 2023; 9 10.1038/s41523-023-00600-8
• Statin Use, Cholesterol Level, and Mortality Among Females With Breast Cancer Cite
  Murto MO, Simolin N, Arponen O, Siltari A, Artama M, Visvanathan K, et al. Statin Use, Cholesterol Level, and Mortality Among Females With Breast Cancer. JAMA Network Open. American Medical Association (AMA); 2023; 6:e2343861 10.1001/jamanetworkopen.2023.43861
• Breast Cancer Incidence After a False-Positive Mammography Result Cite
  Mao X, He W, Humphreys K, Eriksson M, Holowko N, Yang H, et al. Breast Cancer Incidence After a False-Positive Mammography Result. JAMA Oncology. American Medical Association (AMA); 2023; 10.1001/jamaoncol.2023.4519
• In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model Cite
  Pham PD, Muchadeyi MT, Lindholm L. In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model. Cost Effectiveness and Resource Allocation. Springer Science and Business Media LLC; 2023; 21 10.1186/s12962-023-00495-z
• Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer Cite
  Busund M, Ursin G, Lund E, Wilsgaard T, Rylander C. Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2023; 25 10.1186/s13058-023-01729-x
• Risk of breast cancer in daughters of agricultural workers in Denmark Cite
  Elbaek Pedersen J, Hansen J. Risk of breast cancer in daughters of agricultural workers in Denmark. Environmental Research. Elsevier BV; 2023;:117374 10.1016/j.envres.2023.117374
• Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study Cite
  Schiza A, Fredriksson I, Sund M, Valachis A. Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07129-1
• The dose–response relationship of pre-menopausal alcohol consumption with age at menopause: a population study of 280 497 women in Norway Cite
  Langås JR, Eskild A, Hofvind S, Bjelland EK. The dose–response relationship of pre-menopausal alcohol consumption with age at menopause: a population study of 280 497 women in Norway. International Journal of Epidemiology. Oxford University Press (OUP); 2023; 10.1093/ije/dyad129
• Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study Cite
  Löfling LL, Støer NC, Andreassen BK, Ursin G, Botteri E. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2023; 25 10.1186/s13058-023-01697-2
• Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer Cite
  Öfverholm A, Törngren T, Rosén A, Arver B, Einbeigi Z, Haraldsson K, et al. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer. Springer Science and Business Media LLC; 2023; 23 10.1186/s12885-023-11229-y
• Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers Cite
  Wang Q, Zhang Y, Zeng E, Grassmann F, He W, Czene K. Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad104
• Quantifying regional feed utilization, production and nutrient waste emission of Norwegian salmon cage aquaculture Cite
  Wang C, Olsen Y. Quantifying regional feed utilization, production and nutrient waste emission of Norwegian salmon cage aquaculture. Aquaculture Environment Interactions. Inter-Research Science Center; 2023; 15:231-249 10.3354/aei00463
• The Role of Long-Term Physical Activity in Relation to Cancer-Related Health Outcomes: A 12-Month Follow-up of the Phys-Can RCT Cite
  Mazzoni A, Helgesen Bjørke AC, Stenling A, Börjeson S, Sjövall K, Berntsen S, et al. The Role of Long-Term Physical Activity in Relation to Cancer-Related Health Outcomes: A 12-Month Follow-up of the Phys-Can RCT. Integrative Cancer Therapies. SAGE Publications; 2023; 22 10.1177/15347354231178869
• Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women Cite
  Hammarström M, Gabrielson M, Crippa A, Discacciati A, Eklund M, Lundholm C, et al. Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women. British Journal of Cancer. Springer Science and Business Media LLC; 2023; 129:61-71 10.1038/s41416-023-02293-z
• Menopausal hormone therapy and dementia: nationwide, nested case-control study Cite
  Pourhadi N, Mørch LS, Holm EA, Torp-Pedersen C, Meaidi A. Menopausal hormone therapy and dementia: nationwide, nested case-control study. BMJ. BMJ; 2023;:e072770 10.1136/bmj-2022-072770
• Risk of ER-specific breast cancer by family history of ER subtypes and other cancers Cite
  Wang Q, Zhang Y, Zeng E, Grassmann F, He W, Czene K. Risk of ER-specific breast cancer by family history of ER subtypes and other cancers. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad104
• Prediction of breast cancer risk for sisters of women attending screening Cite
  Mao X, He W, Eriksson M, Lindström LS, Holowko N, Bajalica-Lagercrantz S, et al. Prediction of breast cancer risk for sisters of women attending screening. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad101
• Investigating the prognostic value of mammographic breast density and mammographic tumor appearance in women with invasive breast cancer: The Malmö Diet and cancer study Cite
  Sturesdotter L, Larsson A, Zackrisson S, Sartor H. Investigating the prognostic value of mammographic breast density and mammographic tumor appearance in women with invasive breast cancer: The Malmö Diet and cancer study. The Breast. Elsevier BV; 2023; 10.1016/j.breast.2023.05.004
• Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study Cite
  Bengtsson Y, Demircan K, Vallon-Christersson J, Malmberg M, Saal LH, Rydén L, et al. Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study. Redox Biology. Elsevier BV; 2023; 63:102728 10.1016/j.redox.2023.102728
• Risk of All-Cause Dementia, Alzheimer Disease, and Vascular Dementia in Breast Cancer Survivors Cite
  Wennberg A, Ding M, Feychting M, Modig K. Risk of All-Cause Dementia, Alzheimer Disease, and Vascular Dementia in Breast Cancer Survivors. Neurology: Clinical Practice. Ovid Technologies (Wolters Kluwer Health); 2023; 13:e200173 10.1212/cpj.0000000000200173
• Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy Cite
  Nordenskjöld A, Fohlin H, Rosell J, Bengtsson N, Fornander T, Hatschek T, et al. Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-2856174/v1
• Familial aggregation of early‐onset cancers in early‐onset breast cancer families Cite
  Rantala JNJ, Heikkinen SMM, Hirvonen EM, Tanskanen T, Malila NK, Pitkäniemi JM. Familial aggregation of early‐onset cancers in early‐onset breast cancer families. International Journal of Cancer. Wiley; 2023; 10.1002/ijc.34538
• Parental occupational exposure to chemicals and risk of breast cancer in female offspring Cite
  Pedersen JE, Hansen J. Parental occupational exposure to chemicals and risk of breast cancer in female offspring. Environmental Research. Elsevier BV; 2023;:115817 10.1016/j.envres.2023.115817
• The association between night shift work and breast cancer risk in the Finnish twins cohort Cite
  Schernhammer E, Bogl L, Hublin C, Strohmaier S, Zebrowska M, Erber A, et al. The association between night shift work and breast cancer risk in the Finnish twins cohort. European Journal of Epidemiology. Springer Science and Business Media LLC; 2023; 10.1007/s10654-023-00983-9
• O-25 Night work and breast cancer in a cohort of female health care employees in Stockholm, Sweden Cite
  Gustavsson P, Andersson T, Kader M, Selander J, Bodin T, Albin M, et al. O-25 Night work and breast cancer in a cohort of female health care employees in Stockholm, Sweden. Abstracts. BMJ Publishing Group Ltd; 2023; 10.1136/oem-2023-epicoh.61
• Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk Cite
  Sund M, Garmo H, Andersson A, Margolin S, Ahlgren J, Valachis A. Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-06871-w
• Carrot Intake and Risk of Developing Cancer: A Prospective Cohort Study Cite
  Deding U, Baatrup G, Kaalby L, Kobaek-Larsen M. Carrot Intake and Risk of Developing Cancer: A Prospective Cohort Study. Nutrients. MDPI AG; 2023; 15:678 10.3390/nu15030678
• Associations of breast cancer related exposures and gene expression profiles in normal breast tissue—The Norwegian Women and Cancer normal breast tissue study Cite
  Krum‐Hansen S, Standahl Olsen K, Anderssen E, Frantzen JO, Lund E, Paulssen RH. Associations of breast cancer related exposures and gene expression profiles in normal breast tissue—The Norwegian Women and Cancer normal breast tissue study. Cancer Reports. Wiley; 2023; 10.1002/cnr2.1777
• Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes Cite
  Pedersen DC, Jensen BW, Tjønneland A, Andersen ZJ, Mellemkjaer L, Bjerregaard LG, et al. Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes. Breast Cancer Research. Springer Science and Business Media LLC; 2022; 24 10.1186/s13058-022-01578-0
• Breast Density and Risk of Breast Cancer Cite
  Lynge E, Vjeborg I, Lillholm M, Nielsen M, Napolitano G, von Euler‐Chelpin M. Breast Density and Risk of Breast Cancer. International Journal of Cancer. Wiley; 2022; 10.1002/ijc.34316
• Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden Cite
  Lindman H, Wiklund F, Andersen KK. Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden. BMC Cancer. Springer Science and Business Media LLC; 2022; 22 10.1186/s12885-022-10098-1
• Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study Cite
  Liikanen JS, Leidenius M, Joensuu H, Meretoja TJ. Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study. Breast Care. S. Karger AG; 2022; 17:279-287 10.1159/000520793
• Postmenopausal overweight and breast cancer risk; results from the KARMA cohort Cite
  Klintman M, Rosendahl AH, Randeris B, Eriksson M, Czene K, Hall P, et al. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06664-7
• Varying outcomes of triple-negative breast cancer in different age groups - prognostic value of clinical features and proliferation Cite
  Vihervuori H, Korpinen K, Autere T, Repo H, Talvinen K, Kronqvist P. Varying outcomes of triple-negative breast cancer in different age groups - prognostic value of clinical features and proliferation. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1902788/v1
• Shift work with and without night shifts and breast cancer risk in a cohort study from Finland Cite
  Härmä M, Ojajärvi A, Koskinen A, Lie J, Hansen J. Shift work with and without night shifts and breast cancer risk in a cohort study from Finland. Occupational and Environmental Medicine. BMJ; 2022;:oemed-2022-108347 10.1136/oemed-2022-108347
• Time to Mammographic Density Decrease After Exposure to Tamoxifen Cite
  Bäcklund M, Eriksson M, Hammarström M, Thoren L, Bergqvist J, Margolin S, et al. Time to Mammographic Density Decrease After Exposure to Tamoxifen. The Oncologist. Oxford University Press (OUP); 2022; 27:e601-e603 10.1093/oncolo/oyac104
• Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15–34 years of age: A nationwide register-based study Cite
  Niemeyer Hultstrand J, Gemzell-Danielsson K, Kallner HK, Lindman H, Wikman P, Sundström-Poromaa I. Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15–34 years of age: A nationwide register-based study. The Lancet Regional Health - Europe. Elsevier BV; 2022; 21:100470 10.1016/j.lanepe.2022.100470
• Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial Cite
  Johansson A, Dar H, van ’t Veer LJ, Tobin NP, Perez-Tenorio G, Nordenskjöld A, et al. Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 10.1200/jco.21.02844
• Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study Cite
  Cold S, Cold F, Jensen M, Cronin-Fenton D, Christiansen P, Ejlertsen B. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2022; 10.1093/jnci/djac112
• Adjuvant Hormone Therapy–Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis Cite
  Zeng E, He W, Smedby KE, Czene K. Adjuvant Hormone Therapy–Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2022; 20:683-689.e2 10.6004/jnccn.2021.7116
• β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis Cite
  Løfling LL, Støer NC, Sloan EK, Chang A, Gandini S, Ursin G, et al. β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis. British Journal of Cancer. Springer Science and Business Media LLC; 2022; 10.1038/s41416-022-01891-7
• Incidence of New-Onset Type 2 Diabetes After Cancer: A Danish Cohort Study Cite
  Sylow L, Grand MK, von Heymann A, Persson F, Siersma V, Kriegbaum M, et al. Incidence of New-Onset Type 2 Diabetes After Cancer: A Danish Cohort Study. Diabetes Care. American Diabetes Association; 2022; 45:e105-e106 10.2337/dc22-0232
• Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study Cite
  Valachis A, Carlqvist P, Ma Y, Szilcz M, Freilich J, Vertuani S, et al. Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study. British Journal of Cancer. Springer Science and Business Media LLC; 2022; 10.1038/s41416-022-01845-z
• Risk of breast cancer in Danish women occupationally exposed to organic solvents, including ethanol Cite
  Pedersen JE, Strandberg‐Larsen K, Andersson M, Hansen J. Risk of breast cancer in Danish women occupationally exposed to organic solvents, including ethanol. American Journal of Industrial Medicine. Wiley; 2022; 10.1002/ajim.23397
• Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland Cite
  Pallonen TA, Lempiäinen SMM, Joutsiniemi TK, Aaltonen RI, Pohjola PE, Kankuri-Tammilehto MK. Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland. Scientific Reports. Springer Science and Business Media LLC; 2022; 12 10.1038/s41598-022-10519-y
• Cumulative risk of a false‐positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway Cite
  Tsuruda KM, Larsen M, Román M, Hofvind S. Cumulative risk of a false‐positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway. Cancer. Wiley; 2021; 128:1373-1380 10.1002/cncr.34078
• Abstract P3-18-03: Long-term outcomes for breast conservation plus radiotherapy versus mastectomy in early breast cancer after neoadjuvant systemic therapy: Results from the Swedish national breast cancer register (NKBC) Cite
  Wang K, Duinmeijer A, Matikas A, Altena R, Johansson H, Fredholm H, et al. Abstract P3-18-03: Long-term outcomes for breast conservation plus radiotherapy versus mastectomy in early breast cancer after neoadjuvant systemic therapy: Results from the Swedish national breast cancer register (NKBC). Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P3-18-03-P3-18-03 10.1158/1538-7445.sabcs21-p3-18-03
• The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study Cite
  Lofterød T, Frydenberg H, Veierød MB, Jenum AK, Reitan JB, Wist EA, et al. The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study. Acta Oncologica. Informa UK Limited; 2022;:1-9 10.1080/0284186x.2022.2053573
• Employment and risk of female breast cancer in Denmark Cite
  Pedersen JE, Hansen J. Employment and risk of female breast cancer in Denmark. American Journal of Industrial Medicine. Wiley; 2022; 10.1002/ajim.23342
• Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort Cite
  Strandberg R, Czene K, Eriksson M, Hall P, Humphreys K. Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2022;:cebp.1011.2021 10.1158/1055-9965.epi-21-1011
• Night shift work, chemical coexposures and risk of female breast cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort: a prospectively recruited case-cohort study Cite
  Liu FC, Veierød MB, Kjærheim K, Robsahm TE, Ghiasvand R, Hosgood HD, et al. Night shift work, chemical coexposures and risk of female breast cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort: a prospectively recruited case-cohort study. BMJ Open. BMJ; 2022; 12:e056396 10.1136/bmjopen-2021-056396
• Use of beta‐blockers and risk of contralateral breast cancer Cite
  Gottschau M, Bens A, Friis S, Cronin‐Fenton D, Aalborg GL, Jensen M, et al. Use of beta‐blockers and risk of contralateral breast cancer. International Journal of Cancer. Wiley; 2022; 10.1002/ijc.33923
• Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-Term Results From the Swedish Obese Subjects Study Cite
  Sjöholm K, Carlsson LM, Svensson P, Andersson-Assarsson JC, Kristensson F, Jacobson P, et al. Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-Term Results From the Swedish Obese Subjects Study. Diabetes Care. American Diabetes Association; 2021;:dc211335 10.2337/dc21-1335
• Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study Cite
  Harborg S, Ahern TP, Feldt M, Rosendahl AH, Cronin-Fenton D, Melander O, et al. Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06462-7
• Excess risk of male breast cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort: a possible link to extreme night shift work? Cite
  Liu F, Veierød MB, Kjærheim K, Robsahm TE, Ghiasvand R, Babigumira R, et al. Excess risk of male breast cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort: a possible link to extreme night shift work?. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01485-w
• The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis Cite
  Pedersen RN, Esen BÖ, Mellemkjær L, Christiansen P, Ejlertsen B, Lash TL, et al. The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2021; 10.1093/jnci/djab202
• Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study Cite
  Zheng G, Sundquist J, Sundquist K, Ji J. Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study. BMC Cancer. Springer Science and Business Media LLC; 2021; 21 10.1186/s12885-021-08925-y
• Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study Cite
  Collin LJ, Maliniak ML, Cronin-Fenton DP, Ahern TP, Christensen KB, Ulrichsen SP, et al. Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01480-1
• Occupational exposure to solar ultraviolet B radiation and risk of subtypes of breast cancer in Danish women Cite
  Pedersen JE, Strandberg-Larsen K, Andersson M, Hansen J. Occupational exposure to solar ultraviolet B radiation and risk of subtypes of breast cancer in Danish women. Occupational and Environmental Medicine. BMJ; 2021; 78:286-292 10.1136/oemed-2020-107125
• Cancer incidence in a Swedish cohort with high exposure to perfluoroalkyl substances in drinking water Cite
  Li H, Hammarstrand S, Midberg B, Xu Y, Li Y, Olsson DS, et al. Cancer incidence in a Swedish cohort with high exposure to perfluoroalkyl substances in drinking water. Environmental Research. Elsevier BV; 2021;:112217 10.1016/j.envres.2021.112217
• Growth Rate in Childhood and Adolescence and Risk of Breast and Prostate Cancer: A Population-Based Study Cite
  Haraldsdottir A, Steingrimsdottir L, Maskarinec G, Adami H, Aspelund T, Valdimarsdottir UA, et al. Growth Rate in Childhood and Adolescence and Risk of Breast and Prostate Cancer: A Population-Based Study. American Journal of Epidemiology. Oxford University Press (OUP); 2021; 10.1093/aje/kwab250
• Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland Cite
  Taipale H, Solmi M, Lähteenvuo M, Tanskanen A, Correll CU, Tiihonen J. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. The Lancet Psychiatry. Elsevier BV; 2021; 10.1016/s2215-0366(21)00241-8
• Association between overall diet quality and postmenopausal breast cancer risk in five Finnish cohort studies Cite
  Männistö S, Harald K, Härkänen T, Maukonen M, Eriksson JG, Heikkinen S, et al. Association between overall diet quality and postmenopausal breast cancer risk in five Finnish cohort studies. Scientific Reports. Springer Science and Business Media LLC; 2021; 11 10.1038/s41598-021-95773-2
• Never-smokers and the fraction of breast cancer attributable to second-hand smoke from parents during childhood: the Norwegian Women and Cancer Study 1991–2018 Cite
  Gram IT, Wiik AB, Lund E, Licaj I, Braaten T. Never-smokers and the fraction of breast cancer attributable to second-hand smoke from parents during childhood: the Norwegian Women and Cancer Study 1991–2018. International Journal of Epidemiology. Oxford University Press (OUP); 2021; 10.1093/ije/dyab153
• Is cadmium a risk factor for breast cancer - results from a nested case-control study using data from the Malmö Diet and Cancer Study Cite
  Andersson EM, Sandsveden M, Forsgard N, Sallsten G, Manjer J, Engstrom G, et al. Is cadmium a risk factor for breast cancer - results from a nested case-control study using data from the Malmö Diet and Cancer Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.0181.2021 10.1158/1055-9965.epi-21-0181
• Molecular Genetic Characterization of a Subset of Women With Early Breast Cancer Followed Up for 25 Years in the Stockholm Tamoxifen Clinical Trial Cite
  Burton RC. Molecular Genetic Characterization of a Subset of Women With Early Breast Cancer Followed Up for 25 Years in the Stockholm Tamoxifen Clinical Trial. JAMA Network Open. American Medical Association (AMA); 2021; 4:e2115227 10.1001/jamanetworkopen.2021.15227
• Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden Cite
  Johansson A, Christakou AE, Iftimi A, Eriksson M, Tapia J, Skoog L, et al. Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden. JAMA Network Open. American Medical Association (AMA); 2021; 4:e2114716 10.1001/jamanetworkopen.2021.14716
• Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes Cite
  Hosio M, Urpilainen E, Hautakoski A, Marttila M, Arffman M, Sund R, et al. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes. Scientific Reports. Springer Science and Business Media LLC; 2021; 11 10.1038/s41598-021-88488-x
• Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion Cite
  Lilleborge M, Falk RS, Sørlie T, Ursin G, Hofvind S. Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion. International Journal of Cancer. Wiley; 2021; 10.1002/ijc.33680
• Lifestyle changes and risk of cancer: experience from the Swedish women's lifestyle and health cohort study Cite
  Botteri E, Berstad P, Sandin S, Weiderpass E. Lifestyle changes and risk of cancer: experience from the Swedish women's lifestyle and health cohort study. Acta Oncologica. Informa UK Limited; 2021;:1-8 10.1080/0284186x.2021.1919756
• 6P 25-year survival and benefit from tamoxifen therapy by the clinically used breast cancer markers in lymph node-negative and ER-positive/HER2-negative breast cancer Cite
  Dar H, Johansson A, Nordensköljd A, Iftimi A, Yau C, Perez-Tenorio G, et al. 6P 25-year survival and benefit from tamoxifen therapy by the clinically used breast cancer markers in lymph node-negative and ER-positive/HER2-negative breast cancer. Annals of Oncology. Elsevier BV; 2021; 32:S23 10.1016/j.annonc.2021.03.020
• Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status Cite
  de Boniface J, Szulkin R, Johansson ALV. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status. JAMA Surgery. American Medical Association (AMA); 2021; 10.1001/jamasurg.2021.1438
• Risk of breast cancer in relation to dietary intake of selenium and serum selenium as a marker of dietary intake: a prospective cohort study within The Malmö Diet and Cancer Study Cite
  Bengtsson Y, Sandsveden M, Manjer J. Risk of breast cancer in relation to dietary intake of selenium and serum selenium as a marker of dietary intake: a prospective cohort study within The Malmö Diet and Cancer Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2021; 10.1007/s10552-021-01433-1
• Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: A prospective nested case-control study Cite
  Bengtsson Y, Sandsveden M, Borgquist S, Manjer J. Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: A prospective nested case-control study. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-326905/v1
• Prediagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics Cite
  Sandsveden M, Nilsson E, Borgquist S, Rosendahl AH, Manjer J. Prediagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics. International Journal of Cancer. Wiley; 2020; 147:2424-2436 10.1002/ijc.33031
• Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial Cite
  Eriksson M, Eklund M, Borgquist S, Hellgren R, Margolin S, Thoren L, et al. Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021;:JCO.20.02598 10.1200/jco.20.02598
• Early-life risk factors for breast cancer - prospective follow-up in the Northern Finland Birth Cohort 1966 Cite
  Tastula A, Jukkola A, Alakokkare A, Nordström T, Eteläinen S, Karihtala P, et al. Early-life risk factors for breast cancer - prospective follow-up in the Northern Finland Birth Cohort 1966. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.1442.2020 10.1158/1055-9965.epi-20-1442
• Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis Cite
  Janeva S, Zhang C, Kovács A, Parris TZ, Crozier JA, Pezzi CM, et al. Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis. The Lancet Healthy Longevity. Elsevier BV; 2020; 1:e117-e124 10.1016/s2666-7568(20)30018-0
• Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status Cite
  Olafsdottir EJ, Borg A, Jensen M, Gerdes A, Johansson ALV, Barkardottir RB, et al. Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status. British Journal of Cancer. Springer Science and Business Media LLC; 2020; 123:1608-1615 10.1038/s41416-020-01056-4
• Cytotoxic T-cells mediate exercise-induced reductions in tumor growth Cite
  Rundqvist H, Veliça P, Barbieri L, Gameiro PA, Bargiela D, Gojkovic M, et al. Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. eLife. eLife Sciences Publications, Ltd; 2020; 9 10.7554/elife.59996
• Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study Cite
  Mukama T, Fallah M, Brenner H, Xu X, Sundquist K, Sundquist J, et al. Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study. BMC Medicine. Springer Science and Business Media LLC; 2020; 18 10.1186/s12916-020-01772-x
• Effectiveness of Population-Based Service Screening with Mammography for Women Aged 70–74 Years in Sweden Cite
  Mao Z, Nyström L, Jonsson H. Effectiveness of Population-Based Service Screening with Mammography for Women Aged 70–74 Years in Sweden. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:2149-2156 10.1158/1055-9965.epi-20-0523
• Occupational exposure to specific organic solvents and risk of subtypes of breast cancer in a large population of Danish women, 1964–2016 Cite
  Pedersen JE, Strandberg-Larsen K, Andersson M, Hansen J. Occupational exposure to specific organic solvents and risk of subtypes of breast cancer in a large population of Danish women, 1964–2016. Occupational and Environmental Medicine. BMJ; 2020;:oemed-2020-106865 10.1136/oemed-2020-106865
• Long-term consumption of non-fermented and fermented dairy products and risk of breast cancer by estrogen receptor status – Population-based prospective cohort study Cite
  Kaluza J, Komatsu S, Lauriola M, Harris HR, Bergkvist L, Michaëlsson K, et al. Long-term consumption of non-fermented and fermented dairy products and risk of breast cancer by estrogen receptor status – Population-based prospective cohort study. Clinical Nutrition. Elsevier BV; 2020; 10.1016/j.clnu.2020.09.013
• Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study Cite
  Sundbøll J, Farkas DK, Adelborg K, Schapira L, Tamang S, Nørgaard M, et al. Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 184:825-837 10.1007/s10549-020-05879-w
• Evidence for Increased Susceptibility to Breast Cancer From Exposure to Ionizing Radiation Due to a Familial History of Breast Cancer: Results From the Swedish Hemangioma Cohort Cite
  Eidemüller M, Holmberg E, Lundell M, Karlsson P. Evidence for Increased Susceptibility to Breast Cancer From Exposure to Ionizing Radiation Due to a Familial History of Breast Cancer: Results From the Swedish Hemangioma Cohort. American Journal of Epidemiology. Oxford University Press (OUP); 2020; 10.1093/aje/kwaa163
• Smoking cessation prolongs survival in female cancer survivors - the Danish nurse cohort Cite
  Heberg J, Simonsen MK, Thomsen T, Zoffmann V, Danielsen AK. Smoking cessation prolongs survival in female cancer survivors - the Danish nurse cohort. European Journal of Oncology Nursing. Elsevier BV; 2020; 47:101796 10.1016/j.ejon.2020.101796
• Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study Cite
  Harborg S, Heide-Jørgensen U, Ahern TP, Ewertz M, Cronin-Fenton D, Borgquist S. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 183:153-160 10.1007/s10549-020-05749-5
• Risk of primary gastrointestinal cancers following incident non-metastatic breast cancer: a Danish population-based cohort study Cite
  Adelborg K, Farkas DK, Sundbøll J, Schapira L, Tamang S, Cullen MR, et al. Risk of primary gastrointestinal cancers following incident non-metastatic breast cancer: a Danish population-based cohort study. BMJ Open Gastroenterology. BMJ; 2020; 7:e000413 10.1136/bmjgast-2020-000413
• Cancer Risk After Bariatric Surgery in a Cohort Study from the Five Nordic Countries Cite
  Tao W, Santoni G, von Euler-Chelpin M, Ljung R, Lynge E, Pukkala E, et al. Cancer Risk After Bariatric Surgery in a Cohort Study from the Five Nordic Countries. Obesity Surgery. Springer Science and Business Media LLC; 2020; 30:3761-3767 10.1007/s11695-020-04751-6
• Prediagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics Cite
  Sandsveden M, Nilsson E, Borgquist S, Rosendahl AH, Manjer J. Prediagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics. International Journal of Cancer. Wiley; 2020; 147:2424-2436 10.1002/ijc.33031
• Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women Cite
  Duffy SW, Tabár L, Yen AM, Dean PB, Smith RA, Jonsson H, et al. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women. Cancer. Wiley; 2020; 126:2971-2979 10.1002/cncr.32859
• Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study Cite
  Lofterød T, Frydenberg H, Flote V, Eggen AE, McTiernan A, Mortensen ES, et al. Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:215-227 10.1007/s10549-020-05679-2
• Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study Cite
  Bjarnadottir O, Feldt M, Inasu M, Bendahl P, Elebro K, Kimbung S, et al. Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-019-57323-9
• The impact of alcohol consumption and physical activity on breast cancer: The role of breast cancer risk Cite
  Rainey L, Eriksson M, Trinh T, Czene K, Broeders MJ, Waal D, et al. The impact of alcohol consumption and physical activity on breast cancer: The role of breast cancer risk. International Journal of Cancer. Wiley; 2019; 147:931-939 10.1002/ijc.32846
• CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer Cite
  He W, Grassmann F, Eriksson M, Eliasson E, Margolin S, Thorén L, et al. CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:548-557 10.1200/jco.19.01535
• Use of skincare products and risk of cancer of the breast and endometrium: a prospective cohort study Cite
  Rylander C, Veierød MB, Weiderpass E, Lund E, Sandanger TM. Use of skincare products and risk of cancer of the breast and endometrium: a prospective cohort study. Environmental Health. Springer Science and Business Media LLC; 2019; 18 10.1186/s12940-019-0547-6
• Influence of pre-operative oral carbohydrate loading vs. standard fasting procedure on tumor proliferation and clinical outcome in breast cancer patients — a randomized trial Cite
  Lende TH, Austdal M, Varhaugvik AE, Skaland I, Gudlaugsson E, Kvaløy JT, et al. Influence of pre-operative oral carbohydrate loading vs. standard fasting procedure on tumor proliferation and clinical outcome in breast cancer patients — a randomized trial. Research Square; 2019; 10.21203/rs.2.11085/v3
• Mammographic Density and Screening Sensitivity, Breast Cancer Incidence and Associated Risk Factors in Danish Breast Cancer Screening Cite
  Lynge E, Vejborg I, Andersen Z, von Euler-Chelpin M, Napolitano G. Mammographic Density and Screening Sensitivity, Breast Cancer Incidence and Associated Risk Factors in Danish Breast Cancer Screening. Journal of Clinical Medicine. MDPI AG; 2019; 8:2021 10.3390/jcm8112021
• 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival Cite
  Kanstrup C, Teilum D, Rejnmark L, Bigaard JV, Eiken P, Kroman N, et al. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 179:699-708 10.1007/s10549-019-05486-4
• Investigating the risk of breast cancer among women exposed to chemicals: a nested case–control study using improved exposure estimates Cite
  Videnros C, Selander J, Wiebert P, Albin M, Plato N, Borgquist S, et al. Investigating the risk of breast cancer among women exposed to chemicals: a nested case–control study using improved exposure estimates. International Archives of Occupational and Environmental Health. Springer Science and Business Media LLC; 2019; 93:261-269 10.1007/s00420-019-01479-4
• Occupational exposures and male breast cancer: A nested case-control study in the Nordic countries Cite
  Talibov M, Hansen J, Heikkinen S, Martinsen J, Sparen P, Tryggvadottir L, et al. Occupational exposures and male breast cancer: A nested case-control study in the Nordic countries. The Breast. Elsevier BV; 2019; 48:65-72 10.1016/j.breast.2019.09.004
• Risk of breast cancer by prior screening results among women participating in BreastScreen Norway Cite
  Lilleborge M, Falk RS, Russnes H, Sauer T, Ursin G, Hofvind S. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway. Cancer. Wiley; 2019; 125:3330-3337 10.1002/cncr.32330
• O6A.2 Breast cancer risk in 40.000 danish women by industry Cite
  Pedersen JE, Hansen J. O6A.2 Breast cancer risk in 40.000 danish women by industry. Occupational and Environmental Medicine. BMJ; 2019; 76:A51.1-A51 10.1136/oem-2019-epi.137
• Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study Cite
  Ahern TP, Broe A, Lash TL, Cronin-Fenton DP, Ulrichsen SP, Christiansen PM, et al. Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 37:1800-1809 10.1200/jco.18.02202
• Postmenopausal breast cancer and occupational exposure to chemicals Cite
  Videnros C, Selander J, Wiebert P, Albin M, Plato N, Borgquist S, et al. Postmenopausal breast cancer and occupational exposure to chemicals. Scandinavian Journal of Work, Environment & Health. Scandinavian Journal of Work, Environment and Health; 2019; 45:642-650 10.5271/sjweh.3822
• The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women Cite
  Katuwal S, Tapanainen JS, Pukkala E, Kauppila A. The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-5404-z
• Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes Cite
  Hosio M, Urpilainen E, Marttila M, Hautakoski A, Arffman M, Sund R, et al. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 175:741-748 10.1007/s10549-019-05185-0
• Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial Cite
  Ekholm M, Bendahl P, Fernö M, Nordenskjöld B, Stål O, Rydén L. Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial. European Journal of Cancer. Elsevier BV; 2019; 110:53-61 10.1016/j.ejca.2018.12.034
• The “cancer–cold” hypothesis and possible extensions for the Nordic populations Cite
  Voskarides K. The “cancer–cold” hypothesis and possible extensions for the Nordic populations. Scandinavian Journal of Public Health. SAGE Publications; 2019; 47:477-481 10.1177/1403494819831905
• Surgical treatment and prognosis of breast cancer in elderly – A population-based study Cite
  Ojala K, Meretoja TJ, Mattson J, Leidenius MH. Surgical treatment and prognosis of breast cancer in elderly – A population-based study. European Journal of Surgical Oncology. Elsevier BV; 2019; 45:956-962 10.1016/j.ejso.2019.01.019
• No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study Cite
  Frisk G, Ekberg S, Lidbrink E, Eloranta S, Sund M, Fredriksson I, et al. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study. Breast Cancer Research. Springer Science and Business Media LLC; 2018; 20 10.1186/s13058-018-1065-0
• Long-term exposure to road traffic noise and incidence of breast cancer: a cohort study Cite
  Andersen ZJ, Jørgensen JT, Elsborg L, Lophaven SN, Backalarz C, Laursen JE, et al. Long-term exposure to road traffic noise and incidence of breast cancer: a cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2018; 20 10.1186/s13058-018-1047-2
• Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study Cite
  Bens A, Friis S, Dehlendorff C, Jensen M, Ejlertsen B, Kroman N, et al. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study. Preventive Medicine. Elsevier BV; 2018; 116:186-193 10.1016/j.ypmed.2018.09.015
• Occupational variation in the risk of female breast cancer in the Nordic countries Cite
  Katuwal S, Martinsen JI, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, et al. Occupational variation in the risk of female breast cancer in the Nordic countries. Cancer Causes & Control. Springer Science and Business Media LLC; 2018; 29:1027-1038 10.1007/s10552-018-1076-2
• Number of Risky Lifestyle Behaviors and Breast Cancer Risk Cite
  Ellingjord-Dale M, Vos L, Vik Hjerkind K, Hjartåker A, Russnes HG, Tretli S, et al. Number of Risky Lifestyle Behaviors and Breast Cancer Risk. JNCI Cancer Spectrum. Oxford University Press (OUP); 2018; 2 10.1093/jncics/pky030
• Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes Cite
  Lofterød T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, et al. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4568-2
• Different menopausal hormone regimens and risk of breast cancer Cite
  Brusselaers N, Tamimi R, Konings P, Rosner B, Adami H, Lagergren J. Different menopausal hormone regimens and risk of breast cancer. Annals of Oncology. Elsevier BV; 2018; 29:1771-1776 10.1093/annonc/mdy212
• Long-term benefit from tamoxifen therapy for patients with Luminal A and Luminal B breast cancer: Retrospective analysis of the STO-3 trial. Cite
  Lindström L, Yu N, Iftimi A, Yau C, van 't Veer L, Nordenskjöld B, et al. Long-term benefit from tamoxifen therapy for patients with Luminal A and Luminal B breast cancer: Retrospective analysis of the STO-3 trial.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:541-541 10.1200/jco.2018.36.15_suppl.541
• Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women – The Danish Diet, Cancer and Health cohort Cite
  Kyrø C, Hansen L, Frederiksen K, Nørskov NP, Bach Knudsen KE, Eriksen AK, et al. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women – The Danish Diet, Cancer and Health cohort. Clinical Nutrition. Elsevier BV; 2018; 37:2217-2225 10.1016/j.clnu.2017.10.023
• Occupational exposure to organic solvents and risk of male breast cancer: a European multicenter case-control study Cite
  Laouali N, Pilorget C, Cyr D, Neri M, Kaerlev L, Sabroe S, et al. Occupational exposure to organic solvents and risk of male breast cancer: a European multicenter case-control study. Scandinavian Journal of Work, Environment & Health. Scandinavian Journal of Work, Environment and Health; 2018; 44:310-322 10.5271/sjweh.3717
• Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study Cite
  Busund M, Bugge NS, Braaten T, Waaseth M, Rylander C, Lund E. Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study. International Journal of Cancer. Wiley; 2018; 142:2293-2302 10.1002/ijc.31266
• Breast cancer extent and survival among diabetic women in a Finnish nationwide cohort study Cite
  Murto M, Artama M, Pukkala E, Visvanathan K, Murtola T. Breast cancer extent and survival among diabetic women in a Finnish nationwide cohort study. International Journal of Cancer. Wiley; 2018; 142:2227-2233 10.1002/ijc.31250
• The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study Cite
  Holm-Rasmussen EV, Jensen M, Balslev E, Kroman N, Tvedskov TF. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study. European Journal of Cancer. Elsevier BV; 2017; 87:1-9 10.1016/j.ejca.2017.09.037
• Worse survival after breast cancer in women with anorexia nervosa Cite
  Bens A, Papadopoulos FC, Pukkala E, Ekbom A, Gissler M, Mellemkjær L. Worse survival after breast cancer in women with anorexia nervosa. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 168:495-500 10.1007/s10549-017-4618-5
• Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries Cite
  Meijer M, Thygesen LC, Green A, Emneus M, Brasso K, Iversen P, et al. Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries. Cancer Medicine. Wiley; 2017; 7:254-260 10.1002/cam4.1273
• No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study Cite
  Lund E, Nakamura A, Thalabard J. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study. European Journal of Cancer. Elsevier BV; 2018; 89:102-112 10.1016/j.ejca.2017.11.003
• Alcohol consumption and mammographic density in the Danish Diet, Cancer and Health cohort Cite
  Jacobsen KK, Lynge E, Tjønneland A, Vejborg I, von Euler-Chelpin M, Andersen ZJ. Alcohol consumption and mammographic density in the Danish Diet, Cancer and Health cohort. Cancer Causes & Control. Springer Science and Business Media LLC; 2017; 28:1429-1439 10.1007/s10552-017-0970-3
• Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women – The Danish Diet, Cancer and Health cohort Cite
  Kyrø C, Hansen L, Frederiksen K, Nørskov NP, Bach Knudsen KE, Eriksen AK, et al. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women – The Danish Diet, Cancer and Health cohort. Clinical Nutrition. Elsevier BV; 2018; 37:2217-2225 10.1016/j.clnu.2017.10.023
• Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial Cite
  Sjöström M, Lundstedt D, Hartman L, Holmberg E, Killander F, Kovács A, et al. Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:3222-3229 10.1200/jco.2017.72.7263
• Dietary pattern in late life and risk of breast cancer Cite
  Haraldsdottir A, Torfadottir J, Birgisdottir B, Valdimarsdottir U, Aspelund T, Tryggvadottir L, et al. Dietary pattern in late life and risk of breast cancer. European Journal of Public Health. Oxford University Press (OUP); 2017; 27 10.1093/eurpub/ckx187.459
• CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population Cite
  Hallamies S, Pelttari LM, Poikonen-Saksela P, Jekunen A, Jukkola-Vuorinen A, Auvinen P, et al. CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population. BMC Cancer. Springer Science and Business Media LLC; 2017; 17 10.1186/s12885-017-3631-8
• Active smoking and risk of breast cancer in a Danish nurse cohort study Cite
  Andersen ZJ, Jørgensen JT, Grøn R, Brauner EV, Lynge E. Active smoking and risk of breast cancer in a Danish nurse cohort study. BMC Cancer. Springer Science and Business Media LLC; 2017; 17 10.1186/s12885-017-3546-4
• Abstract 2281: Environmental tobacco smoke exposure and breast cancer risk in the Norwegian women and cancer study cohort Cite
  Gram IT, Braaten T, Lund E, Licaj I. Abstract 2281: Environmental tobacco smoke exposure and breast cancer risk in the Norwegian women and cancer study cohort. Epidemiology. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-2281
• Selenium and breast cancer risk: A prospective nested case-control study on serum selenium levels, smoking habits and overweight Cite
  Sandsveden M, Manjer J. Selenium and breast cancer risk: A prospective nested case-control study on serum selenium levels, smoking habits and overweight. International Journal of Cancer. Wiley; 2017; 141:1741-1750 10.1002/ijc.30875
• Clinical outcomes of female breast cancer according to BRCA mutation status Cite
  Cronin-Fenton DP, Kjærsgaard A, Nørgaard M, Pedersen IS, Thomassen M, Kaye JA, et al. Clinical outcomes of female breast cancer according to BRCA mutation status. Cancer Epidemiology. Elsevier BV; 2017; 49:128-137 10.1016/j.canep.2017.05.016
• Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study Cite
  Eriksen KT, McElroy JA, Harrington JM, Levine KE, Pedersen C, Sørensen M, et al. Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study. Journal of the National Cancer Institute. Oxford University Press (OUP); 2016; 109:djw204 10.1093/jnci/djw204
• Estrogen–progestin use and breast cancer characteristics in lean and overweight postmenopausal women Cite
  Kjartansdottir OJ, Sigurdardottir LG, Olafsdottir EJ, Jonasson JG, Ursin G, Tryggvadottir L. Estrogen–progestin use and breast cancer characteristics in lean and overweight postmenopausal women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 163:363-373 10.1007/s10549-017-4171-2
• Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program Cite
  Ellingjord-Dale M, Vos L, Tretli S, Hofvind S, dos-Santos-Silva I, Ursin G. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. Breast Cancer Research. Springer Science and Business Media LLC; 2017; 19 10.1186/s13058-016-0798-x
• Survival After Early-Stage Breast Cancer of Women Previously Treated for Depression: A Nationwide Danish Cohort Study Cite
  Suppli NP, Johansen C, Kessing LV, Toender A, Kroman N, Ewertz M, et al. Survival After Early-Stage Breast Cancer of Women Previously Treated for Depression: A Nationwide Danish Cohort Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:334-342 10.1200/jco.2016.68.8358
• Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study Cite
  de Boniface J, Frisell J, Bergkvist L, Andersson Y. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study. British Journal of Surgery. Oxford University Press (OUP); 2017; 104:238-247 10.1002/bjs.10411
• Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences Cite
  Valla M, Vatten LJ, Engstrøm MJ, Haugen OA, Akslen LA, Bjørngaard JH, et al. Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2016; 25:1625-1634 10.1158/1055-9965.epi-16-0427
• Associations of parity-related reproductive histories with ER± and HER2± receptor-specific breast cancer aetiology Cite
  Anderson WF, Pfeiffer RM, Wohlfahrt J, Ejlertsen B, Jensen M, Kroman N. Associations of parity-related reproductive histories with ER± and HER2± receptor-specific breast cancer aetiology. International Journal of Epidemiology. Oxford University Press (OUP); 2016;:dyw286 10.1093/ije/dyw286
• The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden Cite
  Sackey H, Hui M, Czene K, Verkooijen H, Edgren G, Frisell J, et al. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden. Breast Cancer Research. Springer Science and Business Media LLC; 2016; 18 10.1186/s13058-016-0764-7
• Early Life Residence, Fish Consumption, and Risk of Breast Cancer Cite
  Haraldsdottir A, Steingrimsdottir L, Valdimarsdottir UA, Aspelund T, Tryggvadottir L, Harris TB, et al. Early Life Residence, Fish Consumption, and Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2016; 26:346-354 10.1158/1055-9965.epi-16-0473-t
• Differences in survival for patients with familial and sporadic cancer Cite
  Lee M, Reilly M, Lindström LS, Czene K. Differences in survival for patients with familial and sporadic cancer. International Journal of Cancer. Wiley; 2016; 140:581-590 10.1002/ijc.30476
• Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study Cite
  Ording AG, Heide-Jørgensen U, Christiansen CF, Nørgaard M, Acquavella J, Sørensen HT. Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2016; 34:93-101 10.1007/s10585-016-9824-8
• Cause-specific mortality in women with breast cancerin situ Cite
  He W, Sofie Lindström L, Hall P, Czene K. Cause-specific mortality in women with breast cancerin situ. International Journal of Cancer. Wiley; 2016; 140:2414-2421 10.1002/ijc.30413
• Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies Cite
  Wulaningsih W, Sagoo H, Hamza M, Melvin J, Holmberg L, Garmo H, et al. Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies. International Journal of Molecular Sciences. MDPI AG; 2016; 17:1487 10.3390/ijms17091487
• Incidence of cancer in adolescent idiopathic scoliosis patients treated 25 years previously Cite
  Simony A, Hansen EJ, Christensen SB, Carreon LY, Andersen MO. Incidence of cancer in adolescent idiopathic scoliosis patients treated 25 years previously. European Spine Journal. Springer Science and Business Media LLC; 2016; 25:3366-3370 10.1007/s00586-016-4747-2
• Long-term outcome in young women with breast cancer: a population-based study Cite
  Fredholm H, Magnusson K, Lindström LS, Garmo H, Fält SE, Lindman H, et al. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 160:131-143 10.1007/s10549-016-3983-9
• Physical activity and survival in breast cancer Cite
  Ammitzbøll G, Søgaard K, Karlsen RV, Tjønneland A, Johansen C, Frederiksen K, et al. Physical activity and survival in breast cancer. European Journal of Cancer. Elsevier BV; 2016; 66:67-74 10.1016/j.ejca.2016.07.010
• Abstract 1759: The association between alcohol, physical activity and breast cancer subtypes in a nested case-control study from the Norwegian Breast Cancer Screening Program Cite
  Ellingjord-Dale M, Vos L, Tretli S, Hofvind S, dos-Santos-Silva I, Ursin G. Abstract 1759: The association between alcohol, physical activity and breast cancer subtypes in a nested case-control study from the Norwegian Breast Cancer Screening Program. Epidemiology. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-1759
• ABO blood group and risk of cancer: A register-based cohort study of 1.6 million blood donors Cite
  Vasan SK, Hwang J, Rostgaard K, Nyrén O, Ullum H, Pedersen OB, et al. ABO blood group and risk of cancer: A register-based cohort study of 1.6 million blood donors. Cancer Epidemiology. Elsevier BV; 2016; 44:40-43 10.1016/j.canep.2016.06.005
• Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort Cite
  Dias JA, Fredrikson GN, Ericson U, Gullberg B, Hedblad B, Engström G, et al. Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0158959 10.1371/journal.pone.0158959
• Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: A nested case–control study Cite
  Shirazi L, Almquist M, Borgquist S, Malm J, Manjer J. Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: A nested case–control study. The Breast. Elsevier BV; 2016; 28:184-190 10.1016/j.breast.2016.06.002
• The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012 Cite
  Gram IT, Little MA, Lund E, Braaten T. The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012. British Journal of Cancer. Springer Science and Business Media LLC; 2016; 115:616-623 10.1038/bjc.2016.154
• Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort Cite
  Persson M, Simonsson M, Markkula A, Rose C, Ingvar C, Jernström H. Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort. British Journal of Cancer. Springer Science and Business Media LLC; 2016; 115:382-390 10.1038/bjc.2016.174
• Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer Cite
  Søgaard M, Farkas DK, Ording AG, Sørensen HT, P Cronin-Fenton D. Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2016; 115:588-591 10.1038/bjc.2016.150
• Five year change in alcohol intake and risk of breast cancer and coronary heart disease among postmenopausal women: prospective cohort study Cite
  Dam MK, Hvidtfeldt UA, Tjønneland A, Overvad K, Grønbæk M, Tolstrup JS. Five year change in alcohol intake and risk of breast cancer and coronary heart disease among postmenopausal women: prospective cohort study. BMJ. BMJ; 2016;:i2314 10.1136/bmj.i2314
• Incidence of Cancer and Infertility, in Patients Treated for Adolescent Idiopathic Scoliosis 25 Years Prior Cite
  Simony A, Carreon LY, Christensen SB, Andersen MØ. Incidence of Cancer and Infertility, in Patients Treated for Adolescent Idiopathic Scoliosis 25 Years Prior. Global Spine Journal. SAGE Publications; 2016; 6:s-0036-1582918-s-0036-1582918 10.1055/s-0036-1582918
• Diabetes, diabetes treatment, and mammographic density in Danish Diet, Cancer, and Health cohort Cite
  Buschard K, Thomassen K, Lynge E, Vejborg I, Tjønneland A, von Euler-Chelpin M, et al. Diabetes, diabetes treatment, and mammographic density in Danish Diet, Cancer, and Health cohort. Cancer Causes & Control. Springer Science and Business Media LLC; 2016; 28:13-21 10.1007/s10552-016-0829-z
• Abstract P1-07-20: The smoking related risk of breast cancer and proportion of avoidable breast cancer cases due to passive and active smoking in middle-aged women in Norway in 2012: The Norwegian women and cancer study 1991-2012 Cite
  Gram I, Little M, Lund E, Braaten T. Abstract P1-07-20: The smoking related risk of breast cancer and proportion of avoidable breast cancer cases due to passive and active smoking in middle-aged women in Norway in 2012: The Norwegian women and cancer study 1991-2012. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p1-07-20
• Abstract P4-11-05: Safety of fertility preservation indicated by a diagnosis of breast cancer: A Swedish registry-matched cohort study Cite
  Rodriguez-Wallberg K, Eloranta S, Krawiec K, Lissmats A, Liljegren A. Abstract P4-11-05: Safety of fertility preservation indicated by a diagnosis of breast cancer: A Swedish registry-matched cohort study. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p4-11-05
• Burden of disease of dietary exposure to acrylamide in Denmark Cite
  Jakobsen LS, Granby K, Knudsen VK, Nauta M, Pires SM, Poulsen M. Burden of disease of dietary exposure to acrylamide in Denmark. Food and Chemical Toxicology. Elsevier BV; 2016; 90:151-159 10.1016/j.fct.2016.01.021
• Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival Cite
  Frydenberg H, Thune I, Lofterød T, Mortensen ES, Eggen AE, Risberg T, et al. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 155:345-354 10.1007/s10549-015-3671-1
• Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment Cite
  Heikkinen S, Koskenvuo M, Malila N, Sarkeala T, Pukkala E, Pitkäniemi J. Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment. Cancer Causes & Control. Springer Science and Business Media LLC; 2015; 27:249-258 10.1007/s10552-015-0702-5
• Survival in familial and non-familial breast cancer by age and stage at diagnosis Cite
  Kharazmi E, Försti A, Sundquist K, Hemminki K. Survival in familial and non-familial breast cancer by age and stage at diagnosis. European Journal of Cancer. Elsevier BV; 2016; 52:10-18 10.1016/j.ejca.2015.09.015
• Pregnancy history and risk of premenopausal breast cancer—a nested case-control study Cite
  Hajiebrahimi M, Cnattingius S, Lambe M, Bahmanyar S. Pregnancy history and risk of premenopausal breast cancer—a nested case-control study. International Journal of Epidemiology. Oxford University Press (OUP); 2015; 45:816-824 10.1093/ije/dyv293
• The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer Cite
  Möller S, Mucci LA, Harris JR, Scheike T, Holst K, Halekoh U, et al. The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2015; 25:145-150 10.1158/1055-9965.epi-15-0913
• Supplemental folic acid in pregnancy and maternal cancer risk Cite
  Mortensen JHS, Øyen N, Fomina T, Melbye M, Tretli S, Vollset SE, et al. Supplemental folic acid in pregnancy and maternal cancer risk. Cancer Epidemiology. Elsevier BV; 2015; 39:805-811 10.1016/j.canep.2015.10.009
• Does Hair Dye Use Increase the Risk of Breast Cancer? A Population-Based Case-Control Study of Finnish Women Cite
  Heikkinen S, Pitkäniemi J, Sarkeala T, Malila N, Koskenvuo M. Does Hair Dye Use Increase the Risk of Breast Cancer? A Population-Based Case-Control Study of Finnish Women. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0135190 10.1371/journal.pone.0135190
• Abstract 855: History of oral contraceptive use in breast cancer patients and risk for early breast cancer events Cite
  Huzell L, Persson M, Simonsson M, Markkula A, Ingvar C, Rose C, et al. Abstract 855: History of oral contraceptive use in breast cancer patients and risk for early breast cancer events. Epidemiology. American Association for Cancer Research; 2015; 10.1158/1538-7445.am2015-855
• Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland Cite
  Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E. Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland. Obstetrics & Gynecology. Ovid Technologies (Wolters Kluwer Health); 2014; 124:292-299 10.1097/aog.0000000000000356
• Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study Cite
  Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Joensuu H, et al. Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study. Acta Oncologica. Informa UK Limited; 2015; 55:188-192 10.3109/0284186x.2015.1062538
• Association between inflammatory potential of diet and mortality among women in the Swedish Mammography Cohort Cite
  Shivappa N, Harris H, Wolk A, Hebert JR. Association between inflammatory potential of diet and mortality among women in the Swedish Mammography Cohort. European Journal of Nutrition. Springer Science and Business Media LLC; 2015; 55:1891-1900 10.1007/s00394-015-1005-z
• Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk Cite
  Melander O, Orho-Melander M, Manjer J, Svensson T, Almgren P, Nilsson PM, et al. Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:2632-2638 10.1200/jco.2014.59.7682
• Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients Cite
  Wulaningsih W, Holmberg L, Garmo H, Malmstrom H, Lambe M, Hammar N, et al. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients. Carcinogenesis. Oxford University Press (OUP); 2015; 36:1121-1128 10.1093/carcin/bgv096
• Posttraumatic stress disorder and cancer risk: a nationwide cohort study Cite
  Gradus JL, Farkas DK, Svensson E, Ehrenstein V, Lash TL, Milstein A, et al. Posttraumatic stress disorder and cancer risk: a nationwide cohort study. European Journal of Epidemiology. Springer Science and Business Media LLC; 2015; 30:563-568 10.1007/s10654-015-0032-7
• Inflammatory markers in relation to long-term air pollution Cite
  Mostafavi N, Vlaanderen J, Chadeau-Hyam M, Beelen R, Modig L, Palli D, et al. Inflammatory markers in relation to long-term air pollution. Environment International. Elsevier BV; 2015; 81:1-7 10.1016/j.envint.2015.04.003
• No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study Cite
  Nordenskjöld A, Fohlin H, Albertsson P, Arnesson L, Chamalidou C, Einbeigi Z, et al. No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study. Annals of Oncology. Elsevier BV; 2015; 26:1149-1154 10.1093/annonc/mdv159
• History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response Cite
  Huzell L, Persson M, Simonsson M, Markkula A, Ingvar C, Rose C, et al. History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 149:505-515 10.1007/s10549-014-3252-8
• Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland Cite
  Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E. Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e110231 10.1371/journal.pone.0110231
• Lifestyle influences on the association between pre-diagnostic hormone replacement therapy and breast cancer prognosis—Results from The Danish ‘Diet, Cancer and Health’ prospective cohort Cite
  Holm M, Olsen A, Kroman N, Tjønneland A. Lifestyle influences on the association between pre-diagnostic hormone replacement therapy and breast cancer prognosis—Results from The Danish ‘Diet, Cancer and Health’ prospective cohort. Maturitas. Elsevier BV; 2014; 79:442-448 10.1016/j.maturitas.2014.09.004
• Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer Cite
  Lindström L, Li J, Lee M, Einbeigi Z, Hartman M, Hall P, et al. Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer. Annals of Oncology. Elsevier BV; 2014; 25:1966-1972 10.1093/annonc/mdu270
• Dietary Cadmium Intake and Risk of Breast, Endometrial and Ovarian Cancer in Danish Postmenopausal Women: A Prospective Cohort Study Cite
  Eriksen KT, Halkjær J, Sørensen M, Meliker JR, McElroy JA, Tjønneland A, et al. Dietary Cadmium Intake and Risk of Breast, Endometrial and Ovarian Cancer in Danish Postmenopausal Women: A Prospective Cohort Study. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e100815 10.1371/journal.pone.0100815
• Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer Cite
  Huss L, Butt S, Borgquist S, Almquist M, Malm J, Manjer J. Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer. Cancer Causes & Control. Springer Science and Business Media LLC; 2014; 25:1131-1140 10.1007/s10552-014-0413-3
• Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: A nationwide family study Cite
  Zöller B, Li X, Sundquist J, Sundquist K. Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: A nationwide family study. European Journal of Cancer. Elsevier BV; 2014; 50:2319-2327 10.1016/j.ejca.2014.05.018
• Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden Cite
  Holmes MD, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson TM, et al. Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden. BMC Cancer. Springer Science and Business Media LLC; 2014; 14 10.1186/1471-2407-14-391
• Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort Cite
  Elebro K, Butt S, Dorkhan M, Jernström H, Borgquist S. Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort. Cancer Causes & Control. Springer Science and Business Media LLC; 2014; 25:945-957 10.1007/s10552-014-0394-2
• Development in self-reported arm-lymphedema in Danish women treated for early-stage breast cancer in 2005 and 2006 – A nationwide follow-up study Cite
  Gärtner R, Mejdahl MK, Andersen KG, Ewertz M, Kroman N. Development in self-reported arm-lymphedema in Danish women treated for early-stage breast cancer in 2005 and 2006 – A nationwide follow-up study. The Breast. Elsevier BV; 2014; 23:445-452 10.1016/j.breast.2014.03.001
• Physical activity and the risk of postmenopausal breast cancer - the Norwegian Women and Cancer Study Cite
  Borch KB, Lund E, Braaten T, Weiderpass E. Physical activity and the risk of postmenopausal breast cancer - the Norwegian Women and Cancer Study. Journal of Negative Results in BioMedicine. Springer Science and Business Media LLC; 2014; 13 10.1186/1477-5751-13-3
• Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor Cite
  Narbe U, Bendahl P, Grabau D, Rydén L, Ingvar C, Fernö M. Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor. SpringerPlus. Springer Science and Business Media LLC; 2014; 3 10.1186/2193-1801-3-70
• Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status Cite
  Nilsson MP, Hartman L, Idvall I, Kristoffersson U, Johannsson OT, Loman N. Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 144:133-142 10.1007/s10549-014-2842-9
• Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics Cite
  Colzani E, Johansson ALV, Liljegren A, Foukakis T, Clements M, Adolfsson J, et al. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. British Journal of Cancer. Springer Science and Business Media LLC; 2014; 110:1378-1384 10.1038/bjc.2014.5
• Commercial processed food may have endocrine-disrupting potential: soy-based ingredients making the difference Cite
  Omoruyi IM, Kabiersch G, Pohjanvirta R. Commercial processed food may have endocrine-disrupting potential: soy-based ingredients making the difference. Food Additives & Contaminants: Part A. Informa UK Limited; 2013; 30:1722-1727 10.1080/19440049.2013.817025
• Vitamin C intake and breast cancer mortality in a cohort of Swedish women Cite
  Harris HR, Bergkvist L, Wolk A. Vitamin C intake and breast cancer mortality in a cohort of Swedish women. British Journal of Cancer. Springer Science and Business Media LLC; 2013; 109:257-264 10.1038/bjc.2013.269
• Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status Cite
  Simonsson M, Söderlind V, Henningson M, Hjertberg M, Rose C, Ingvar C, et al. Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status. Cancer Causes & Control. Springer Science and Business Media LLC; 2013; 24:929-940 10.1007/s10552-013-0169-1
• Mediterranean Dietary Pattern and Risk of Breast Cancer Cite
  Couto E, Sandin S, Löf M, Ursin G, Adami H, Weiderpass E. Mediterranean Dietary Pattern and Risk of Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e55374 10.1371/journal.pone.0055374
• Familial risk of early and late onset cancer: nationwide prospective cohort study Cite
  Kharazmi E, Fallah M, Sundquist K, Hemminki K. Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ. BMJ; 2012; 345:e8076-e8076 10.1136/bmj.e8076
• Health effects and exposure to polychlorinated biphenyls (PCBs) and metals in a contaminated community Cite
  Helmfrid I, Berglund M, Löfman O, Wingren G. Health effects and exposure to polychlorinated biphenyls (PCBs) and metals in a contaminated community. Environment International. Elsevier BV; 2012; 44:53-58 10.1016/j.envint.2012.01.009
• Hormone Therapy Use and Breast Cancer Incidence by Histological Subtypes in Sweden and Norway Cite
  Suhrke P, Maehlen J, Zahl P. Hormone Therapy Use and Breast Cancer Incidence by Histological Subtypes in Sweden and Norway. The Breast Journal. Wiley; 2012; 18:549-556 10.1111/tbj.12001
• Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based Study Cite
  Vichapat V, Garmo H, Holmqvist M, Liljegren G, Wärnberg F, Lambe M, et al. Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:3478-3485 10.1200/jco.2011.39.3645
• Content of heterocyclic amines and polycyclic aromatic hydrocarbons in pork, beef and chicken barbecued at home by Danish consumers Cite
  Aaslyng MD, Duedahl-Olesen L, Jensen K, Meinert L. Content of heterocyclic amines and polycyclic aromatic hydrocarbons in pork, beef and chicken barbecued at home by Danish consumers. Meat Science. Elsevier BV; 2013; 93:85-91 10.1016/j.meatsci.2012.08.004
• Selenium intake and breast cancer mortality in a cohort of Swedish women Cite
  Harris HR, Bergkvist L, Wolk A. Selenium intake and breast cancer mortality in a cohort of Swedish women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 134:1269-1277 10.1007/s10549-012-2139-9
• Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort Cite
  Markkula A, Bromée A, Henningson M, Hietala M, Ringberg A, Ingvar C, et al. Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort. Cancer Causes & Control. Springer Science and Business Media LLC; 2012; 23:1307-1316 10.1007/s10552-012-0008-9
• Pre-diagnostic alcohol consumption and breast cancer recurrence and mortality: Results from a prospective cohort with a wide range of variation in alcohol intake Cite
  Holm M, Olsen A, Christensen J, Kroman NT, Bidstrup PE, Johansen C, et al. Pre-diagnostic alcohol consumption and breast cancer recurrence and mortality: Results from a prospective cohort with a wide range of variation in alcohol intake. International Journal of Cancer. Wiley; 2012; 132:686-694 10.1002/ijc.27652
• Quantifying Mediating Effects of Endogenous Estrogen and Insulin in the Relation between Obesity, Alcohol Consumption, and Breast Cancer Cite
  Hvidtfeldt UA, Gunter MJ, Lange T, Chlebowski RT, Lane D, Farhat GN, et al. Quantifying Mediating Effects of Endogenous Estrogen and Insulin in the Relation between Obesity, Alcohol Consumption, and Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2012; 21:1203-1212 10.1158/1055-9965.epi-12-0310
• Risk of Primary Non–Breast Cancer After Female Breast Cancer by Age at Diagnosis Cite
  Mellemkjær L, Christensen J, Frederiksen K, Pukkala E, Weiderpass E, Bray F, et al. Risk of Primary Non–Breast Cancer After Female Breast Cancer by Age at Diagnosis. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2011; 20:1784-1792 10.1158/1055-9965.epi-11-0009
• Risk of Breast Cancer After False-Positive Test Results in Screening Mammography Cite
  von Euler-Chelpin M, Risor LM, Thorsted BL, Vejborg I. Risk of Breast Cancer After False-Positive Test Results in Screening Mammography. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:682-689 10.1093/jnci/djs176
• Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden Cite
  Attner B, Landin-Olsson M, Lithman T, Noreen D, Olsson H. Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden. Cancer Causes & Control. Springer Science and Business Media LLC; 2012; 23:769-777 10.1007/s10552-012-9946-5
• Loss of partner and breast cancer prognosis — a population-based study, Denmark, 1994–2010 Cite
  Olsen MH, Bidstrup PE, Frederiksen K, Rod NH, Grønbæk M, Dalton SO, et al. Loss of partner and breast cancer prognosis — a population-based study, Denmark, 1994–2010. British Journal of Cancer. Springer Science and Business Media LLC; 2012; 106:1560-1563 10.1038/bjc.2012.96
• Timing of Familial Breast Cancer in Sisters Cite
  Rebora P, Czene K, Reilly M. Timing of Familial Breast Cancer in Sisters. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2008; 100:721-727 10.1093/jnci/djn146
• Dietary Cadmium Exposure and Risk of Postmenopausal Breast Cancer: A Population-Based Prospective Cohort Study Cite
  Julin B, Wolk A, Bergkvist L, Bottai M, Åkesson A. Dietary Cadmium Exposure and Risk of Postmenopausal Breast Cancer: A Population-Based Prospective Cohort Study. Cancer Research. American Association for Cancer Research (AACR); 2012; 72:1459-1466 10.1158/0008-5472.can-11-0735
• Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study Cite
  Hallas J, Christensen R, Andersen M, Friis S, Bjerrum L. Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study. British Journal of Clinical Pharmacology. Wiley; 2012; 74:180-188 10.1111/j.1365-2125.2012.04170.x
• Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden Cite
  Hietala M, Henningson M, Ingvar C, Jönsson P, Rose C, Jernström H. Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden. Acta Oncologica. Informa UK Limited; 2010; 50:134-143 10.3109/0284186x.2010.484812
• Alcohol intake and mortality among women with invasive breast cancer Cite
  Harris HR, Bergkvist L, Wolk A. Alcohol intake and mortality among women with invasive breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2012; 106:592-595 10.1038/bjc.2011.561
• Risk of breast cancer in families of multiple affected women and men Cite
  Bevier M, Sundquist K, Hemminki K. Risk of breast cancer in families of multiple affected women and men. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:723-728 10.1007/s10549-011-1915-2
• Quantifying differences in breast cancer survival between England and Norway Cite
  Lambert PC, Holmberg L, Sandin F, Bray F, Linklater KM, Purushotham A, et al. Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiology. Elsevier BV; 2011; 35:526-533 10.1016/j.canep.2011.04.003
• Folate intake and breast cancer mortality in a cohort of Swedish women Cite
  Harris HR, Bergkvist L, Wolk A. Folate intake and breast cancer mortality in a cohort of Swedish women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:243-250 10.1007/s10549-011-1838-y
• Proliferative effect of whey from cows' milk obtained at two different stages of pregnancy measured in MCF-7 cells Cite
  Nielsen TS, Andersen C, Sejrsen K, Purup S. Proliferative effect of whey from cows' milk obtained at two different stages of pregnancy measured in MCF-7 cells. Journal of Dairy Research. Cambridge University Press (CUP); 2011; 79:33-38 10.1017/s0022029911000689
• Mammographic Density and Intake of Selected Nutrients and Vitamins in Norwegian Women Cite
  Qureshi SA, Couto E, Hilsen M, Hofvind S, Wu AH, Ursin G. Mammographic Density and Intake of Selected Nutrients and Vitamins in Norwegian Women. Nutrition and Cancer. Informa UK Limited; 2011; 63:1011-1020 10.1080/01635581.2011.605983
• Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression Cite
  Lindström LS, Karlsson E, Wilking UM, Johansson U, Hartman J, Lidbrink EK, et al. Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:2601-2608 10.1200/jco.2011.37.2482
• Breast cancer in very young women Cite
  Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J. Breast cancer in very young women. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1030-1037 10.1016/j.ejso.2011.08.133
• Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study Cite
  Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2011; 13 10.1186/bcr2944
• Case–control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems Cite
  Hansen J, Stevens RG. Case–control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems. European Journal of Cancer. Elsevier BV; 2012; 48:1722-1729 10.1016/j.ejca.2011.07.005
• Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer Cite
  Tvedskov TF, Jensen M, Kroman N, Balslev E. Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 131:223-229 10.1007/s10549-011-1720-y
• Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study Cite
  Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, et al. Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:1461-1468 10.1093/jnci/djr291
• Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden Cite
  McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson N, Bennet AM, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiotherapy and Oncology. Elsevier BV; 2011; 100:167-175 10.1016/j.radonc.2011.06.016
• Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study Cite
  Allin KH, Nordestgaard BG, Flyger H, Bojesen SE. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2011; 13 10.1186/bcr2891
• Coffee consumption modifies risk of estrogen-receptor negative breast cancer Cite
  Li J, Seibold P, Chang-Claude J, Flesch-Janys D, Liu J, Czene K, et al. Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2011; 13 10.1186/bcr2879
• Night Work and Breast Cancer Risk Among Norwegian Nurses: Assessment by Different Exposure Metrics Cite
  Lie JS, Kjuus H, Zienolddiny S, Haugen A, Stevens RG, Kjaerheim K. Night Work and Breast Cancer Risk Among Norwegian Nurses: Assessment by Different Exposure Metrics. American Journal of Epidemiology. Oxford University Press (OUP); 2011; 173:1272-1279 10.1093/aje/kwr014
• Familial Mortality and Familial Incidence in Cancer Cite
  Hemminki K, Sundquist J, Brandt A. Familial Mortality and Familial Incidence in Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:712-718 10.1200/jco.2010.30.5664
• Prediagnostic plasma enterolactone levels and mortality among women with breast cancer Cite
  Olsen A, Christensen J, Knudsen KEB, Johnsen NF, Overvad K, Tjønneland A. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 128:883-889 10.1007/s10549-011-1397-2
• Effect of Obesity on Prognosis After Early-Stage Breast Cancer Cite
  Ewertz M, Jensen M, Gunnarsdóttir KÁ, Højris I, Jakobsen EH, Nielsen D, et al. Effect of Obesity on Prognosis After Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:25-31 10.1200/jco.2010.29.7614
• Long-term observational follow-up study of breast cancer diagnosed in women ≤40 years old Cite
  Karihtala P, Winqvist R, Bloigu R, Jukkola-Vuorinen A. Long-term observational follow-up study of breast cancer diagnosed in women ≤40 years old. The Breast. Elsevier BV; 2010; 19:456-461 10.1016/j.breast.2010.05.001
• Plasma and Urinary Alkylresorcinol Metabolites as Potential Biomarkers of Breast Cancer Risk in Finnish Women: A Pilot Study Cite
  Aubertin-Leheudre M, Koskela A, Samaletdin A, Adlercreutz H. Plasma and Urinary Alkylresorcinol Metabolites as Potential Biomarkers of Breast Cancer Risk in Finnish Women: A Pilot Study. Nutrition and Cancer. Informa UK Limited; 2010; 62:759-764 10.1080/01635581003693058
• Personality Traits and Cancer Risk and Survival Based on Finnish and Swedish Registry Data Cite
  Nakaya N, Bidstrup PE, Saito-Nakaya K, Frederiksen K, Koskenvuo M, Pukkala E, et al. Personality Traits and Cancer Risk and Survival Based on Finnish and Swedish Registry Data. American Journal of Epidemiology. Oxford University Press (OUP); 2010; 172:377-385 10.1093/aje/kwq046
• Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study Cite
  Hellmann SS, Thygesen LC, Tolstrup JS, Grønbæk M. Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2010; 19:366-373 10.1097/cej.0b013e32833b4828
• Micronutrient intake and breast cancer characteristics among postmenopausal women Cite
  Roswall N, Olsen A, Christensen J, Dragsted LO, Overvad K, Tjønneland A. Micronutrient intake and breast cancer characteristics among postmenopausal women. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2010; 19:360-365 10.1097/cej.0b013e32833ade68
• Metabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project Cite
  Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, et al. Metabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2010; 19:1737-1745 10.1158/1055-9965.epi-10-0230
• Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study Cite
  Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes & Control. Springer Science and Business Media LLC; 2010; 21:1533-1544 10.1007/s10552-010-9582-x
• Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer Cite
  Ellberg C, Olsson H. Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer. BMC Cancer. Springer Science and Business Media LLC; 2011; 11 10.1186/1471-2407-11-497
• Discordance in hormone receptor status in breast cancer during tumor progression. Cite
  Karlsson E, Lindström LS, Wilking U, Skoog L, Johansson U, Bergh J. Discordance in hormone receptor status in breast cancer during tumor progression.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1009-1009 10.1200/jco.2010.28.15_suppl.1009
• Effects of childhood body size on breast cancer tumour characteristics Cite
  Li J, Humphreys K, Eriksson L, Czene K, Liu J, Hall P. Effects of childhood body size on breast cancer tumour characteristics. Breast Cancer Research. Springer Science and Business Media LLC; 2010; 12 10.1186/bcr2564
• Multivitamin use and breast cancer incidence in a prospective cohort of Swedish women Cite
  Larsson SC, Åkesson A, Bergkvist L, Wolk A. Multivitamin use and breast cancer incidence in a prospective cohort of Swedish women. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2010; 91:1268-1272 10.3945/ajcn.2009.28837
• Mental Vulnerability and Survival After Cancer Cite
  Nakaya N, Bidstrup PE, Eplov LF, Saito-Nakaya K, Kuriyama S, Tsuji I, et al. Mental Vulnerability and Survival After Cancer. Epidemiology. Ovid Technologies (Wolters Kluwer Health); 2009; 20:916-920 10.1097/ede.0b013e3181b5f3b0
• Use of antibiotics and risk of breast cancer: a population-based case–control study Cite
  Sørensen HT, Skriver MV, Friis S, McLaughlin JK, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case–control study. British Journal of Cancer. Springer Science and Business Media LLC; 2004; 92:594-596 10.1038/sj.bjc.6602313
• Antibiotic use predicts an increased risk of cancer Cite
  Kilkkinen A, Rissanen H, Klaukka T, Pukkala E, Heliövaara M, Huovinen P, et al. Antibiotic use predicts an increased risk of cancer. International Journal of Cancer. Wiley; 2008; 123:2152-2155 10.1002/ijc.23622
• A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women Cite
  Fryzek JP, Ye W, Nyrén O, Tarone RE, Lipworth L, McLaughlin JK. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2005; 97:131-134 10.1007/s10549-005-9099-2
• Risk Factors for Male Breast Cancer?A Case-Control Study from Scandinavia Cite
  Marianne Ewertz LH. Risk Factors for Male Breast Cancer?A Case-Control Study from Scandinavia. Acta Oncologica. Informa UK Limited; 2001; 40:467-471 10.1080/02841860117406
• Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort Cite
  Larsson SC, Bergkvist L, Wolk A. Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Causes & Control. Springer Science and Business Media LLC; 2009; 20:2039-2044 10.1007/s10552-009-9396-x
• Caloric Restriction and Incidence of Breast Cancer Cite
  Michels KB. Caloric Restriction and Incidence of Breast Cancer. JAMA. American Medical Association (AMA); 2004; 291:1226 10.1001/jama.291.10.1226
• The prognostic impact of occult nodal metastasis in early breast carcinoma Cite
  Park D, Kåresen R, Naume B, Synnestvedt M, Beraki E, Sauer T. The prognostic impact of occult nodal metastasis in early breast carcinoma. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 118:57-66 10.1007/s10549-009-0340-2
• Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: a case–cohort study from Denmark Cite
  Witt PM, Christensen JH, Schmidt EB, Dethlefsen C, Tjønneland A, Overvad K, et al. Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: a case–cohort study from Denmark. Cancer Causes & Control. Springer Science and Business Media LLC; 2009; 20:1715-1721 10.1007/s10552-009-9423-y
• Vitamin D3from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway) Cite
  Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes & Control. Springer Science and Business Media LLC; 2004; 15:149-158 10.1023/b:caco.0000019494.34403.09
• Conjugated linoleic acid intake and breast cancer risk in a prospective cohort of Swedish women Cite
  Larsson SC, Bergkvist L, Wolk A. Conjugated linoleic acid intake and breast cancer risk in a prospective cohort of Swedish women. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2009; 90:556-560 10.3945/ajcn.2009.27480
• Enterolactone Is Differently Associated with Estrogen Receptor β–Negative and –Positive Breast Cancer in a Swedish Nested Case-Control Study Cite
  Sonestedt E, Borgquist S, Ericson U, Gullberg B, Olsson H, Adlercreutz H, et al. Enterolactone Is Differently Associated with Estrogen Receptor β–Negative and –Positive Breast Cancer in a Swedish Nested Case-Control Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2008; 17:3241-3251 10.1158/1055-9965.epi-08-0393
• Long-term meat intake and risk of breast cancer by oestrogen and progesterone receptor status in a cohort of Swedish women Cite
  Larsson SC, Bergkvist L, Wolk A. Long-term meat intake and risk of breast cancer by oestrogen and progesterone receptor status in a cohort of Swedish women. European Journal of Cancer. Elsevier BV; 2009; 45:3042-3046 10.1016/j.ejca.2009.04.035
• Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women Cite
  Suzuki R, Rylander-Rudqvist T, Saji S, Bergkvist L, Adlercreutz H, Wolk A. Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women. British Journal of Cancer. Springer Science and Business Media LLC; 2008; 98:636-640 10.1038/sj.bjc.6604175
• Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women Cite
  Larsson SC, Bergkvist L, Wolk A. Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women. International Journal of Cancer. Wiley; 2009; 125:153-157 10.1002/ijc.24310
• Growth Patterns and the Risk of Breast Cancer in Women Cite
  Ahlgren M, Melbye M, Wohlfahrt J, Sørensen TIA. Growth Patterns and the Risk of Breast Cancer in Women. New England Journal of Medicine. Massachusetts Medical Society; 2004; 351:1619-1626 10.1056/nejmoa040576
• Age of onset in familial breast cancer as background data for medical surveillance Cite
  Brandt A, Bermejo JL, Sundquist J, Hemminki K. Age of onset in familial breast cancer as background data for medical surveillance. British Journal of Cancer. Springer Science and Business Media LLC; 2009; 102:42-47 10.1038/sj.bjc.6605421
• Dietary Phytoestrogens Are Not Associated with Risk of Overall Breast Cancer But Diets Rich in Coumestrol Are Inversely Associated with Risk of Estrogen Receptor and Progesterone Receptor Negative Breast Tumors in Swedish Women Cite
  Hedelin M, Löf M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E. Dietary Phytoestrogens Are Not Associated with Risk of Overall Breast Cancer But Diets Rich in Coumestrol Are Inversely Associated with Risk of Estrogen Receptor and Progesterone Receptor Negative Breast Tumors in Swedish Women. The Journal of Nutrition. Oxford University Press (OUP); 2008; 138:938-945 10.1093/jn/138.5.938
• Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort Cite
  Larsson SC, Bergkvist L, Wolk A. Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2004; 80:1353-1357 10.1093/ajcn/80.5.1353
• Determinants of serum concentrations of organochlorine compounds in Swedish pregnant women: a cross-sectional study Cite
  Glynn A, Aune M, Darnerud PO, Cnattingius S, Bjerselius R, Becker W, et al. Determinants of serum concentrations of organochlorine compounds in Swedish pregnant women: a cross-sectional study. Environmental Health. Springer Science and Business Media LLC; 2007; 6 10.1186/1476-069x-6-2
• Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women Cite
  Larsson SC, Bergkvist L, Wolk A. Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2008; 89:277-282 10.3945/ajcn.2008.26704
• Folate Intake and Risk of Breast Cancer by Estrogen and Progesterone Receptor Status in a Swedish Cohort Cite
  Larsson SC, Bergkvist L, Wolk A. Folate Intake and Risk of Breast Cancer by Estrogen and Progesterone Receptor Status in a Swedish Cohort. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2008; 17:3444-3449 10.1158/1055-9965.epi-08-0692
• Mortality in a cohort with high fish consumption Cite
  Turunen AW, Verkasalo PK, Kiviranta H, Pukkala E, Jula A, Mannisto S, et al. Mortality in a cohort with high fish consumption. International Journal of Epidemiology. Oxford University Press (OUP); 2008; 37:1008-1017 10.1093/ije/dyn117
• Linking Exposure to Polychlorinated Biphenyls With Fatty Fish Consumption and Reduced Fetal Growth Among Danish Pregnant Women: A Cause for Concern? Cite
  Halldorsson TI, Thorsdottir I, Meltzer HM, Nielsen F, Olsen SF. Linking Exposure to Polychlorinated Biphenyls With Fatty Fish Consumption and Reduced Fetal Growth Among Danish Pregnant Women: A Cause for Concern?. American Journal of Epidemiology. Oxford University Press (OUP); 2008; 168:958-965 10.1093/aje/kwn204
• Nested Case-Control Study of the Association of Circulating Levels of Serum Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 with Breast Cancer in Young Women in Norway Cite
  Vatten LJ, Holly JM, Gunnell D, Tretli S. Nested Case-Control Study of the Association of Circulating Levels of Serum Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 with Breast Cancer in Young Women in Norway. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2008; 17:2097-2100 10.1158/1055-9965.epi-08-0212
• Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort Cite
  Löf M, Sandin S, Lagiou P, Hilakivi-Clarke L, Trichopoulos D, Adami H, et al. Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort. British Journal of Cancer. Springer Science and Business Media LLC; 2007; 97:1570-1576 10.1038/sj.bjc.6604033
• Interactions between intakes of alcohol and postmenopausal hormones on risk of breast cancer Cite
  Nielsen NR, Grønbaek M. Interactions between intakes of alcohol and postmenopausal hormones on risk of breast cancer. International Journal of Cancer. Wiley; 2007; 122:1109-1113 10.1002/ijc.23195
• Alcohol intake and breast cancer risk among young women Cite
  Berstad P, Ma H, Bernstein L, Ursin G. Alcohol intake and breast cancer risk among young women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2007; 108:113-120 10.1007/s10549-007-9578-8
• Alcohol Intake and Cigarette Smoking and Risk of a Contralateral Breast Cancer: The Women's Environmental Cancer and Radiation Epidemiology Study Cite
  Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, et al. Alcohol Intake and Cigarette Smoking and Risk of a Contralateral Breast Cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. American Journal of Epidemiology. Oxford University Press (OUP); 2009; 169:962-968 10.1093/aje/kwn422